The interaction of angiocidin with tissue transglutaminase
- 28 February 2010
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 88 (1), 15-25
- https://doi.org/10.1016/j.yexmp.2009.11.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Angiostatic activity of obtustatin as α1β1 integrin inhibitor in experimental melanoma growthInternational Journal of Cancer, 2008
- The Novel Angiogenic Inhibitor, Angiocidin, Induces Differentiation of Monocytes to MacrophagesCancer Research, 2008
- Biological and therapeutic significance of tissue transglutaminase in pancreatic cancerAmino Acids, 2008
- Transglutaminase 2 inhibitors and their therapeutic role in disease statesPharmacology & Therapeutics, 2007
- Clinical significance of serum angiocidin levels in hepatocellular carcinomaCancer Letters, 2007
- Tissue Transglutaminase and Celiac DiseasePublished by S. Karger AG ,2005
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilageJournal of Orthopaedic Research, 2002
- Thrombospondin is a substrate for blood coagulation factor XIIIaBiochemistry, 1986
- SPECIFICITY OF FIBRONECTIN‐FIBRIN CROSS‐LINKING*Annals of the New York Academy of Sciences, 1983